tirzepatide anesthesia Perioperative management of patients taking glucagon-like peptide 1 receptor agonists: Society for Perioperative Assessment and Quality Improvement (SPAQI) multidisciplinary consensus statement Zepbound (Tirzepatide) GLP-1 injection -

However, your body may clear the drug entirely from its system quicker than this

doi: 10.1593/tlo.13412 142 Llins-CaballeroKCaraballoL

Theory 1: Glucagon Receptor Activation Retatrutide is the ONLY obesity medication activating glucagon receptors Glucagon affects peripheral nerves and nerve signaling May alter nerve sensitivity temporarily Theory 2: Rapid Metabolic Changes 28.7% weight loss at 68 weeks = very rapid Rapid fat loss changes nerve compression (fat pads around nerves) Metabolic shifts affect nerve function Theory 3: Both Combination of direct glucagon effects + metabolic changes Explains why incidence is dose-dependent (20.9% @ 12mg, 8.8% @ 9mg) Is Dysesthesia Dangerous